Sarfati E - Search Results

1

Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: clinical use and limits.

Toubert ME, Cyna-Gorse F, Zagdanski AM, Noel-Wekstein S, Cattan P, Billotey C, Sarfati E, Rain JD. Toubert ME, et al. Among authors: sarfati e. Thyroid. 1999 Jun;9(6):591-7. doi: 10.1089/thy.1999.9.591. Thyroid. 1999. PMID: 10411122 Clinical Trial.

2

Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome.

Hindié E, Zanotti-Fregonara P, Keller I, Duron F, Devaux JY, Calzada-Nocaudie M, Sarfati E, Moretti JL, Bouchard P, Toubert ME. Hindié E, et al. Among authors: sarfati e. Endocr Relat Cancer. 2007 Sep;14(3):799-807. doi: 10.1677/ERC-07-0120. Endocr Relat Cancer. 2007. PMID: 17914109

3

Early localization and reoperation for persistent primary hyperparathyroidism.

Sarfati E, Billotey C, Halimi B, Fritsch S, Cattan P, Dubost C. Sarfati E, et al. Br J Surg. 1997 Jan;84(1):98-100. Br J Surg. 1997. PMID: 9043469

4

Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery.

de Labriolle-Vaylet C, Cattan P, Sarfati E, Wioland M, Billotey C, Brochériou C, Rouvier E, de Roquancourt A, Rostène W, Askienazy S, Barbet J, Milhaud G, Gruaz-Guyon A. de Labriolle-Vaylet C, et al. Among authors: sarfati e. Clin Cancer Res. 2000 Feb;6(2):363-71. Clin Cancer Res. 2000. PMID: 10690512

5

Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures.

Billotey C, Aurengo A, Najean Y, Sarfati E, Moretti JL, Toubert ME, Rain JD. Billotey C, et al. Among authors: sarfati e. J Nucl Med. 1994 Oct;35(10):1631-6. J Nucl Med. 1994. PMID: 7931661 Free article.

6

Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy.

Billotey C, Sarfati E, Aurengo A, Duet M, Mündler O, Toubert ME, Rain JD, Najean Y. Billotey C, et al. Among authors: sarfati e. J Nucl Med. 1996 Nov;37(11):1773-8. J Nucl Med. 1996. PMID: 8917173 Free article.

7

Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism.

Hindié E, Zanotti-Fregonara P, Just PA, Sarfati E, Mellière D, Toubert ME, Moretti JL, Jeanguillaume C, Keller I, Ureña-Torres P. Hindié E, et al. Among authors: sarfati e. Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):623-34. doi: 10.1007/s00259-009-1313-8. Epub 2009 Nov 28. Eur J Nucl Med Mol Imaging. 2010. PMID: 19946686

8

Reoperation for secondary uremic hyperparathyroidism: are technical difficulties influenced by initial surgical procedure?

Cattan P, Halimi B, Aïdan K, Billotey C, Tamas C, Drüeke TB, Sarfati E. Cattan P, et al. Among authors: sarfati e. Surgery. 2000 May;127(5):562-5. doi: 10.1067/msy.2000.105865. Surgery. 2000. PMID: 10819065

9

Can the morbidity of esophagectomy be reduced by the thoracoscopic approach?

Gossot D, Cattan P, Fritsch S, Halimi B, Sarfati E, Celerier M. Gossot D, et al. Among authors: sarfati e. Surg Endosc. 1995 Oct;9(10):1113-5. doi: 10.1007/BF00188998. Surg Endosc. 1995. PMID: 8553214 Review.

10

Localization of ectopic parathyroid tissue: usefulness of 99mTc sestamibi scanning in a dialysis patient with severe secondary hyperparathyroidism.

Zingraff J, Léger A, Skhiri H, Billotey C, Sarfati E, Drüeke T. Zingraff J, et al. Among authors: sarfati e. Nephrol Dial Transplant. 1996 Dec;11(12):2504-6. doi: 10.1093/oxfordjournals.ndt.a027227. Nephrol Dial Transplant. 1996. PMID: 9017635 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters